Follow

Submissions from 2019

How should my approach to high blood pressure change? Key takeaways from the guidelines and case-based blood pressure pearls, Tyler J Gluckman

How should my approach to hypertension change? Key Takeaways from the Guidelines and Case-based BP Pearls, Tyler J Gluckman

Interprofessional Heart Teams: What are They and Why do I Need Them?, Tyler J Gluckman

Intersection of Antiplatelets and Anticoagulants--What to do When a Patient Needs Both?, Tyler J Gluckman

Intersection of antiplatelets and anticoagulants—What to do when a patient needs both?, Tyler J Gluckman

Making the Most Out of ACCorg: Optimizing Your Experience with Your Digital Home, Tyler J Gluckman

Managing LDL-cholesterol with PCSK9 inhibitors: Identifying the patients, optimizing the outcomes, Tyler J Gluckman

Managing treatment gaps with PCSK9 inhibitors, Tyler J Gluckman

Meeting the triple (quadruple) aim: How do we collectively care for the patient? What does this mean for the health system?, Tyler J Gluckman

Overcoming Access Barriers and Practice Challenges to PCSK9 Inhibitor Implementation, Tyler J Gluckman

PCSK9 inhibitors: Addressing the unmet needs in hypercholesterolemia, Tyler J Gluckman

Pitfalls and challenges in the road to quality: Navigating and avoiding potholes, Tyler J Gluckman

Putting Your NCDR Registry to Work, Tyler J Gluckman

Redesigning quality of care and performance measures for primary and secondary prevention of ASCVD, Tyler J Gluckman

Strategies to Stomp Out Unwanted Clinical Care Variation: A Case-Based Approach, Tyler J Gluckman

Tailoring LDL-C lowering therapy to patient cardiovascular risk: Identifying effective strategies for patients with diabetes, Tyler J Gluckman

Treating high-risk patients with non-statin therapy for LDL-C lowering: Optimizing clinical outcomes, Tyler J Gluckman

What Are These Squiggly Lines? Fast Basics to Interpret 12-Lead ECGs, Benjamin J Hartwig

CCO 20: What can you do to prepare for value-based care, Xiaoyan Huang

HF Forum: Heart Failure Management Beyond Hospitalization, Xiaoyan Huang

Medical Neighborhood 20: Why Should Specialists Care?, Xiaoyan Huang

Prevention Forum: Cardiovascular Disease Prevention: Policy, Guidelines and Strategy, Xiaoyan Huang

Standardized Training of Cardiovascular Specialists: Bridging the Gap: Case Discussion, Xiaoyan Huang

Alternative Access Approaches in TAVR, Eric B Kirker

Case-Based Access Challenges Panel Discussant, Eric B Kirker

Structural IV Panel Discussant, Eric B Kirker

Live Case: Transcarotid TAVR, Eric B Kirker and Ethan C Korngold

Considerations for Managing TAVR and Concomitant Coronary Artery Disease in 2020: Challenging Coronary Access Case, Ethan C Korngold

CTO Crossing 1: Case Examples of Wire Escalation, Ethan C Korngold

Embrace Left Distal Radial Access: It’s the New and Best Approach!, Ethan C Korngold

Large-Bore Access and Closure: Resolution, Ethan C Korngold

Live Cases #6 - Live Case Discussant, Ethan C Korngold

Now That I See It, I Know How To Treat It! Presentation and Hands-On Session 1, Ethan C Korngold

Now That I See It, I Know How To Treat It! Presentation and Hands-On Session 2, Ethan C Korngold

PCI in the OBL/ASC Setting: Is it Safe?, Ethan C Korngold

SFA Intervention: De-Bulking, Complex Lesions, and Definitive Therapy - Training Pavilion Faculty, Ethan C Korngold

Structural Complications: Aortic Annular Rupture, And More, Ethan C Korngold

TAVR With Difficult Access: The Transcarotid Approach, Ethan C Korngold

Assessing limb perfusion: New tools, Alejandro Perez

Medical management of the vascular surgery patient, Alejandro Perez

PAD/CLI: Medical Management, Alejandro Perez

Peripheral arterial disease for the wound care clinician, Alejandro Perez

Peripheral Artery Disease: Basic principles for the wound care clinician, Alejandro Perez

Screening for PAD/CLI, Alejandro Perez

Establishing a treatment pathway for patients with ruptured abdominal aortic aneurysms, Brant Ullery

Evolution of vascular complications and associated treatment strategies in transfemoral transcatheter aortic valve replacement, Brant Ullery

Expanding applicability of TEVAR in the fragile aorta, Brant Ullery

Five-year outcomes from the ENGAGE global registry: treating more challenging anatomy with excellent long-term outcomes, Brant Ullery

I think my patient had claudication, what do I do now?, Brant Ullery

Transcarotid artery revascularization (TCAR): Pitfalls and strategies for success, Brant Ullery

Acute complicated type B dissection with multi-organ system malperfusion, Brant W Ullery

Advances in endovascular surgery, Brant W Ullery

Current advances in TEVAR therapy: Tailoring treatment to the patient and disease, Brant W Ullery

Dynamic geometric changes of the thoracic aorta: implications for TEVAR and branched grafts, Brant W Ullery

Five-year outcomes from the ENGAGE global registry: treating more challenging infrarenal patients with excellent long-term outcomes, Brant W Ullery

Heli-FX in the management of complex aortic disease - midterm results from the Anchor registry, Brant W Ullery

New generation TEVAR device: How Valiant Navion is designed to improve overall TEVAR therapy while on a low-profile platform, Brant W Ullery

Prevention and management of vascular complications in TEVAR, Brant W Ullery

Type II endoleaks and their influence on long-term outcomes: Insights from the ENGAGE global registry, Brant W Ullery

Submissions from 2018

Lower mortality and heart failure hospitalization rates in patients implanted with pulmonary artery pressure sensor--A real-world comparative effectiveness study, Jacob Abraham

Managing Complex Heart Failure Patients with Remote Monitoring? Does PA Pressure Monitoring Help?, Jacob Abraham

Risk metrics, research, appropriate use--Answers to the tough questions, G Dehmer, A Amin, and Tyler J Gluckman

Anticoagulation challenges in patients with dysrhythmias, MD Ezekowitz, SA Spinler, LY Chen, Tyler J Gluckman, TM Maddox, and RB Schnabel

Advances in heart failure management: How will recent guideline changes impact your treatment selections?, Tyler J Gluckman

ASCVD risk estimation to guide the management of hypertension: The time has come, Tyler J Gluckman

Case challenge: Intersection of antiplatelets and anticoagulation, Tyler J Gluckman

Getting Started--Keys to Successful Patient Reported Outcomes (PROs) Implementation, Tyler J Gluckman

Latest Update and Future: How Should I Manage Heparin Induced Thrombocytopenia (HIT)?, Tyler J Gluckman

PCSK9 inhibitors: Addressing the unmet needs in hypercholesterolemia, Tyler J Gluckman

PCSK9 inhibitors: Addressing the unmet needs in hypercholesterolemia, Tyler J Gluckman

Predicting the future: Making sense of risk assessment tools, Tyler J Gluckman

Setting the Stage: The Growing Prevalence of Peripheral Artery Disease, Tyler J Gluckman

Utilizing NCDR data to improve practice and drive clinical research, Tyler J Gluckman

What will drive cardiovascular therapy in the next ten years?, Tyler J Gluckman

Cardiac episodes of care--What are they and now that CMS cancelled them, why do I care?, Tyler J Gluckman, S Farmer, D Itchhaporia, C Biga, and TA Draper

Optimizing your smart phone tools to take better care of your patients, Tyler J Gluckman and AM Freeman

Essentials of coding, documentation and attribution--Making it work in a busy clinic, Tyler J Gluckman and L Gates-Striby

What's your "Type"? Demystifying type 2 myocardial infarction, Tyler J Gluckman and A Goyal

Making your EHR more efficient, accurate and relevant . . . and maybe interoperable, Tyler J Gluckman and R Hendel

Patient Navigator Program-Focus MI workshop, Tyler J Gluckman and J Mobayed

Quality Payment Program (QPP) 101--Help! I need the basics, Tyler J Gluckman and GA Rose

Achieving better access, care coordination, patient experience and operational efficiency through patient centered specialty practice transformation, Xiaoyan Huang and Lesley Jones Larson

Case Presenter: Complex Interventions: Expert Case Reviews - Interventional “Rich Emotional Experiences” (AKA Complications) II: Structural Case #1: A Frightening Vascular Complication After TAVR, Ethan C Korngold

Interactive Faculty Training: SFA Intervention: De-bulking, Complex Lesions, and Definitive Therapy Session III, Ethan C Korngold

Interactive Training Faculty: SFA Intervention, Complex Lesions, Debulking, and Definitive Therapy Session II, Ethan C Korngold

Interactive Training Faculty: Tibiopedal Access BTK (Tibiopedal Access) Session IV, Ethan C Korngold

Target stent and anchor balloon: strategies for complex iliac artery chronic total occlusion crossing, Ethan C Korngold

Update on Carotid Stenting: CREST, ACT1, Ethan C Korngold

Dyslipidemia: Creating harmony in an ever-changing landscape of guidelines, PB Morris, SS Virani, J Knowles, PM Kris-Etherton, Tyler J Gluckman, and KK Ray

Building and implementing a QI program: What's required, who needs to be involved and how best to overcome barriers?, J Tingley, A Amin, and Tyler J Gluckman

Application of heli-fx endoachors in AAAs with hostile neck anatomy – A dinner program, Brant Ullery

Drug-eluting stents in femoropopliteal occlusive disease, Brant Ullery

Endovascular approach to limb salvage, Brant Ullery

Essentials of endovascular aneurysm repair, Brant Ullery

Grand Rounds: Contemporary lower extremity revascularization options, Brant Ullery

Natural history and clinical relevance of gutter-related type Ia endoleaks after chimney EVAR - Chimney EVAR workshop, Brant Ullery

Role of drug-eluting stents in femoropopliteal occlusive disease, Brant Ullery

Streamlining patient care: Developing a ruptured abdominal aortic aneurysm protocol, Brant Ullery

The Endurant stent graft system: results from the ENGAGE registry, Brant Ullery

NCDR performance improvement: The power of clinical data, C Van Vleet, Tyler J Gluckman, J Caldwell, and A Caixeta